Article metrics

Download PDFPDF
IDDF2024-ABS-0205 Impact of long-term treatment with continuous tenofovir alafenamide (TAF) or after switch from tenofovir disoproxil fumarate (TDF) on hepatocellular carcinoma (HCC) incidence in patients with chronic hepatitis B (CHB)

 

Online download statistics by month:

Online download statistics by month: August 2024 to September 2024

AbstractFullPdf
Aug 2024173010
Sep 20246304
Total236014